Cost-effectiveness of natalizumab in patients with Crohn's disease who have failed Anti-TNFα therapy

被引：0
|
作者：
Sands, Bruce
Wolf, Douglas
Panjabi, Sumeet
Niecko, Timothy
Hass, Steven
Lacey, Loretto
机构：
[1] Massachusetts Gen Hosp, Gastrointestinal Unit, MGH Crohns & Colitis Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Atlanta Gastroenterol Associates, Atlanta, GA USA
[4] Elan Pharmaceut Inc, San Francisco, CA USA
[5] LLC, Niecko Hlth Econ, Escondido, CA USA
[6] Elan Pharmaceut Ltd, Pharmacoecon, Dublin, Ireland
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷
关键词：
D O I：
10.14309/00000434-200809001-01025
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1025
引用
收藏
页码：S401 / S402
页数：2
相关论文
共 50 条
  • [21] Effect of anti-TNFα therapy with daily physical activity in patients with Crohn's disease
    Lucca, F. A.
    Malaguti, C.
    Cabalzar, A. L.
    Chebli, L. A.
    Ribeiro, T. C. R.
    Gaburri, P. D.
    Chebli, J. M. F.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S344 - S344
  • [22] The role of pharmacogenomics in the prediction of efficacy of anti-TNF therapy in patients with Crohn's disease
    Mascheretti, S
    Schreiber, S
    PHARMACOGENOMICS, 2004, 5 (05) : 479 - 486
  • [23] Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy
    Franco Leal, Raquel
    Planell, Nuria
    Kajekar, Radhika
    Lozano, Juan J.
    Ordas, Ingrid
    Dotti, Isabella
    Esteller, Miriam
    Carme Masamunt, M.
    Parmar, Harsukh
    Ricart, Elena
    Panes, Julian
    Salas, Azucena
    GUT, 2015, 64 (02) : 233 - 242
  • [24] Anti-TNF therapy is associated with a reduction in radiation exposure in patients with Crohn's disease
    Aggarwal, Divya
    Limdi, Jimmy K.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (01) : 13 - 19
  • [25] WEIGHT ADJUSTED ANTI-TNF THERAPY FAVOURS OBESE PATIENTS WITH CROHN'S DISEASE
    Bhalme, M.
    Sharma, A.
    Keld, R.
    Makin, A.
    Willert, R.
    Campbell, S.
    GUT, 2012, 61 : A228 - A228
  • [26] Use of Anti-TNF Therapy in Patients With Crohn's Disease Complicated by an Abdominal Phlegmon
    O'Donnell, Sarah
    Chawla, Tanya P.
    Nguyen, Geoffrey C.
    Silverberg, Mark S.
    Steinhart, A. Hillary
    Croitoru, Kenneth
    GASTROENTEROLOGY, 2015, 148 (04) : S459 - S459
  • [27] ANTI-TNF THERAPY REDUCES IONISING RADIATION EXPOSURE IN PATIENTS WITH CROHN'S DISEASE
    Aggarwal, D.
    Limdi, J. K.
    GUT, 2014, 63 : A79 - A79
  • [28] Controversies in the management of anti-TNF therapy in patients with Crohn's disease: a Delphi consensus
    Gonzalez-Lama, Yago
    Ricart, Elena
    Carpio, Daniel
    Bastida, Guillermo
    Ceballos, Daniel
    Ginard, Daniel
    Marin-Jimenez, Ignacio
    Menchen, Luis
    Munoz, Fernando
    BMJ OPEN GASTROENTEROLOGY, 2024, 11 (01):
  • [29] Anti-TNF therapy use in pregnant patients with Crohn's disease and ulcerative colitis
    Kiely, C.
    Subramaniam, K.
    Pavli, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 104 - 104
  • [30] Efficacy assessment of natalizumab in patients with Crohn's disease and prior history of anti-TNF therapy: Results from ENACT-1
    Sandborn, WJ
    Colombel, JF
    Enns, R
    Feagan, B
    Hanauer, SB
    Lawrance, I
    Panaccione, R
    Sanders, M
    Schreiber, S
    Targan, SR
    van Deventer, SJ
    Rutgeerts, P
    GASTROENTEROLOGY, 2004, 126 (04) : A76 - A76
12345